Diagnostic Radiopharmaceutical Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
MARKET DYNAMICS
The diagnostic radiopharmaceutical market is driving due to the factors such as increasing prevalence of chronic diseases and improvement of healthcare institutions with safety measures. In addition, development and launch of new products in the developing nations of the world are likely to offer growth opportunities for market players.
MARKET SCOPE
The "Diagnostic Radiopharmaceutical Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diagnostic radiopharmaceutical market with detailed market segmentation by imaging modality and application. The diagnostic radiopharmaceutical market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diagnostic radiopharmaceutical market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The diagnostic radiopharmaceutical market is segmented on the basis of imaging modality and application. Based on imaging modality, the market is segmented as Tc-99, Tl-201, Ga-67, I-123, F-18, Rb-82, and others. On the basis of application, the market is segmented into cardiology, neurology, thyroid, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diagnostic radiopharmaceutical market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diagnostic radiopharmaceutical market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diagnostic radiopharmaceutical market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the diagnostic radiopharmaceutical market in these regions.
![World Geography](https://www.theinsightpartners.com/assets/rdimages/world-geography.png)
Have a question?
![Analyst](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diagnostic radiopharmaceutical market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diagnostic radiopharmaceutical market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diagnostic radiopharmaceutical market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the diagnostic radiopharmaceutical market in these regions.
MARKET PLAYERS
The report covers key developments in the diagnostic radiopharmaceutical market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diagnostic radiopharmaceutical market are anticipated to have lucrative growth opportunities in the future with the rising demand for diagnostic radiopharmaceutical in the global market. Below mentioned is the list of few companies engaged in the diagnostic radiopharmaceutical market.
The report also includes the profiles of key players in diagnostic radiopharmaceutical market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Bayer AG
- General Electric
- Cardinal Health, Inc.
- Nordion Inc.
- Siemens Healthineers
- Bracco Imaging
- Guerbet Group
- Curium
- NTP Radioisotopes
- Lanthus Holdings, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diagnostic Radiopharmaceutical Market - By Imaging Modality
1.3.2 Diagnostic Radiopharmaceutical Market - By Application
1.3.3 Diagnostic Radiopharmaceutical Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - GLOBAL MARKET ANALYSIS
6.1. DIAGNOSTIC RADIOPHARMACEUTICAL - GLOBAL MARKET OVERVIEW
6.2. DIAGNOSTIC RADIOPHARMACEUTICAL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2028 - IMAGING MODALITY
7.1. OVERVIEW
7.2. IMAGING MODALITY MARKET FORECASTS AND ANALYSIS
7.3. TC-99
7.3.1. Overview
7.3.2. Tc-99 Market Forecast and Analysis
7.4. TL-201
7.4.1. Overview
7.4.2. Tl-201 Market Forecast and Analysis
7.5. GA-67
7.5.1. Overview
7.5.2. Ga-67 Market Forecast and Analysis
7.6. I-123
7.6.1. Overview
7.6.2. I-123 Market Forecast and Analysis
7.7. F-18
7.7.1. Overview
7.7.2. F-18 Market Forecast and Analysis
7.8. RB-82
7.8.1. Overview
7.8.2. Rb-82 Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOLOGY
8.3.1. Overview
8.3.2. Cardiology Market Forecast and Analysis
8.4. NEUROLOGY
8.4.1. Overview
8.4.2. Neurology Market Forecast and Analysis
8.5. THYROID
8.5.1. Overview
8.5.2. Thyroid Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diagnostic Radiopharmaceutical Market Overview
9.1.2 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.1.3 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.1.4 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.1.5 North America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diagnostic Radiopharmaceutical Market
9.1.5.1.1 United States Diagnostic Radiopharmaceutical Market by Imaging Modality
9.1.5.1.2 United States Diagnostic Radiopharmaceutical Market by Application
9.1.5.2 Canada Diagnostic Radiopharmaceutical Market
9.1.5.2.1 Canada Diagnostic Radiopharmaceutical Market by Imaging Modality
9.1.5.2.2 Canada Diagnostic Radiopharmaceutical Market by Application
9.1.5.3 Mexico Diagnostic Radiopharmaceutical Market
9.1.5.3.1 Mexico Diagnostic Radiopharmaceutical Market by Imaging Modality
9.1.5.3.2 Mexico Diagnostic Radiopharmaceutical Market by Application
9.2. EUROPE
9.2.1 Europe Diagnostic Radiopharmaceutical Market Overview
9.2.2 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.2.3 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.2.4 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.2.5 Europe Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diagnostic Radiopharmaceutical Market
9.2.5.1.1 Germany Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.1.2 Germany Diagnostic Radiopharmaceutical Market by Application
9.2.5.2 France Diagnostic Radiopharmaceutical Market
9.2.5.2.1 France Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.2.2 France Diagnostic Radiopharmaceutical Market by Application
9.2.5.3 Italy Diagnostic Radiopharmaceutical Market
9.2.5.3.1 Italy Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.3.2 Italy Diagnostic Radiopharmaceutical Market by Application
9.2.5.4 Spain Diagnostic Radiopharmaceutical Market
9.2.5.4.1 Spain Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.4.2 Spain Diagnostic Radiopharmaceutical Market by Application
9.2.5.5 United Kingdom Diagnostic Radiopharmaceutical Market
9.2.5.5.1 United Kingdom Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.5.2 United Kingdom Diagnostic Radiopharmaceutical Market by Application
9.2.5.6 Rest of Europe Diagnostic Radiopharmaceutical Market
9.2.5.6.1 Rest of Europe Diagnostic Radiopharmaceutical Market by Imaging Modality
9.2.5.6.2 Rest of Europe Diagnostic Radiopharmaceutical Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diagnostic Radiopharmaceutical Market Overview
9.3.2 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.3.3 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.3.4 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diagnostic Radiopharmaceutical Market
9.3.5.1.1 Australia Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.1.2 Australia Diagnostic Radiopharmaceutical Market by Application
9.3.5.2 China Diagnostic Radiopharmaceutical Market
9.3.5.2.1 China Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.2.2 China Diagnostic Radiopharmaceutical Market by Application
9.3.5.3 India Diagnostic Radiopharmaceutical Market
9.3.5.3.1 India Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.3.2 India Diagnostic Radiopharmaceutical Market by Application
9.3.5.4 Japan Diagnostic Radiopharmaceutical Market
9.3.5.4.1 Japan Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.4.2 Japan Diagnostic Radiopharmaceutical Market by Application
9.3.5.5 South Korea Diagnostic Radiopharmaceutical Market
9.3.5.5.1 South Korea Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.5.2 South Korea Diagnostic Radiopharmaceutical Market by Application
9.3.5.6 Rest of Asia-Pacific Diagnostic Radiopharmaceutical Market
9.3.5.6.1 Rest of Asia-Pacific Diagnostic Radiopharmaceutical Market by Imaging Modality
9.3.5.6.2 Rest of Asia-Pacific Diagnostic Radiopharmaceutical Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diagnostic Radiopharmaceutical Market Overview
9.4.2 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.4.3 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.4.4 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diagnostic Radiopharmaceutical Market
9.4.5.1.1 South Africa Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.1.2 South Africa Diagnostic Radiopharmaceutical Market by Application
9.4.5.2 Saudi Arabia Diagnostic Radiopharmaceutical Market
9.4.5.2.1 Saudi Arabia Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.2.2 Saudi Arabia Diagnostic Radiopharmaceutical Market by Application
9.4.5.3 U.A.E Diagnostic Radiopharmaceutical Market
9.4.5.3.1 U.A.E Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.3.2 U.A.E Diagnostic Radiopharmaceutical Market by Application
9.4.5.4 Rest of Middle East and Africa Diagnostic Radiopharmaceutical Market
9.4.5.4.1 Rest of Middle East and Africa Diagnostic Radiopharmaceutical Market by Imaging Modality
9.4.5.4.2 Rest of Middle East and Africa Diagnostic Radiopharmaceutical Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diagnostic Radiopharmaceutical Market Overview
9.5.2 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis
9.5.3 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Imaging Modality
9.5.4 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Application
9.5.5 South and Central America Diagnostic Radiopharmaceutical Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diagnostic Radiopharmaceutical Market
9.5.5.1.1 Brazil Diagnostic Radiopharmaceutical Market by Imaging Modality
9.5.5.1.2 Brazil Diagnostic Radiopharmaceutical Market by Application
9.5.5.2 Argentina Diagnostic Radiopharmaceutical Market
9.5.5.2.1 Argentina Diagnostic Radiopharmaceutical Market by Imaging Modality
9.5.5.2.2 Argentina Diagnostic Radiopharmaceutical Market by Application
9.5.5.3 Rest of South and Central America Diagnostic Radiopharmaceutical Market
9.5.5.3.1 Rest of South and Central America Diagnostic Radiopharmaceutical Market by Imaging Modality
9.5.5.3.2 Rest of South and Central America Diagnostic Radiopharmaceutical Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DIAGNOSTIC RADIOPHARMACEUTICAL MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIAGNOSTIC RADIOPHARMACEUTICAL MARKET, KEY COMPANY PROFILES
12.1. BAYER AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENERAL ELECTRIC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CARDINAL HEALTH, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NORDION INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SIEMENS HEALTHINEERS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRACCO IMAGING
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GUERBET GROUP
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CURIUM
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NTP RADIOISOTOPES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LANTHUS HOLDINGS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Bayer AG
2. General Electric
3. Cardinal Health, Inc.
4. Nordion Inc.
5. Siemens Healthineers
6. Bracco Imaging
7. Guerbet Group
8. Curium
9. NTP Radioisotopes
10. Lanthus Holdings, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.